Open Nipple Sparing Mastectomy (NSM)

See also
Status	Clinical Trial	Phase
Completed	`NCT05917834` - Comparison of Nipple-areolar Complex Sensation According to Incision Types in Nipple-sparing Mastectomy
Recruiting	`NCT03892980` - Robotic-Assisted da Vinci Xi Prophylactic Nipple-Sparing Mastectomy	N/A
Not yet recruiting	`NCT06073808` - The Role of Amnion Membrane Allografts in Nipple Preservation	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT05917834 - Comparison of Nipple-areolar Complex Sensation According to Incision Types in Nipple-sparing Mastectomy

Recruiting

NCT03892980 - Robotic-Assisted da Vinci Xi Prophylactic Nipple-Sparing Mastectomy

N/A

Not yet recruiting

NCT06073808 - The Role of Amnion Membrane Allografts in Nipple Preservation

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04447339
Study type	Observational
Source	Intuitive Surgical
Contact	Tish Mikoczi
Phone	760-274-5811
Email	tish.mikoczi@intusurg.com
Status	Recruiting
Phase
Start date	September 21, 2020
Completion date	December 31, 2024

Open Nipple Sparing Mastectomy (NSM) — NSM Open

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms